SCHEMBL30202695

SCHEMBL30202695

CCOC(=O)c1cnc(C)c(NC(=O)c2cnc(NNC)nc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ NFKB1 P19838 3/20 0.40
▸ ATF1 P18846 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ FOS P01100 2/20 0.36
▸ JUN P05412 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30202755 0.86 NFKB1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL24952216 0.86 NFKB1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL24951472 0.75 NFKB1 (0.46) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL24951630 0.73 ALDH1A1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL30202869 0.73 ALDH1A1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL24951126 0.71 NFKB1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL30202837 0.71 NFKB1 (0.50) ALDH1A1KDM4ENFKB1ATF1MAPT
SCHEMBL11363820 0.70 ALDH1A1 (0.54) ALDH1A1KDM4ENFKB1MAPTRAB9A
SCHEMBL29029338 0.70 SMN1; SMN2 (0.48) ALDH1A1KDM4EMAPTPOLBRAB9A
SCHEMBL24577041 0.69 HSD17B10 (0.39) ALDH1A1KDM4EMAPTPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4376845-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS Actelion Pharmaceuticals Ltd (CH) 2024-06-05 — — EP disclosed
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback